[Improvement of climacteric syndrome with MPA treatment (author's transl)].
D000328:Adult; D002979:Climacteric / Q000187:drug effects*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged
D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
IL trattamento della sindrome climaterica con medrossiprogesterone - acetato (MAP).